Showing results (101-110 of 516) with videos related to

Sort By:
Pageof 52
Blood|April 26, 2003
Expression of CD52 on plasma cells in plasma cell proliferative disordersShaji Kumar, Teresa K Kimlinger, John A Lust, et al.
Frontiers in Oncology|February 15, 2021
Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCRQiumei Yao, Yinlei Bai, Shaji Kumar, et al.
Current Opinion in Oncology|February 3, 2007
Transplantation for amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 3, 2020
Impact of CD138 Magnetic Bead-based Positive Selection on Bone Marrow Plasma Cell Surface MarkersRadhika Bansal, Teresa Kimlinger, Kelli Ann Gyotoku, et al.
Haematologica|July 28, 2006
Differential expression of vascular endothelial growth factors and their receptors in multiple myelomaTeresa Kimlinger, Michael Kline, Shaji Kumar, et al.
Blood Advances|April 30, 2025
Predictive Value of Free Light Chain Burden in Patients with AL Amyloidosis Treated with Bortezomib-Based RegimensBrendan Saunders, Foteini Theodorakakou, Despina V Fotiou, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM)Robert A Kyle, Angela Dispenzieri, Shaji Kumar, et al.
Leukemia Research|October 17, 2013
Genetic variants in DNA repair pathways are not associated with disease progression among multiple myeloma patientsBharat Thyagarajan, Mukta Arora, Weihua Guan, et al.
Hematology (Amsterdam, Netherlands)|September 3, 2021
3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myelomaChor Sang Chim, Shaji Kumar, Vincent Kai Chung Wong, et al.
Blood Advances|October 14, 2021
Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survivalTianzeng Chen, Matthew Ho, Jenna Briere, et al.
Pageof 52